4-[[[4-[3-[2-[2-[2-[2-[4-[[3-[[2-[[2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetyl]amino]-1,3-thiazol-5-yl]methyl]phenoxy]methyl]triazol-1-yl]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]benzoyl]amino]methyl]-N-hydroxybenzamide

InChIKey	`UBMHPTAZKYQZMF-UHFFFAOYSA-N`
Compound Name	4-[[[4-[3-[2-[2-[2-[2-[4-[[3-[[2-[[2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetyl]amino]-1,3-thiazol-5-yl]methyl]phenoxy]methyl]triazol-1-yl]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]benzoyl]amino]methyl]-N-hydroxybenzamide
Canonical SMILES	`Cc1cc(C)nc(SCC(=O)Nc2ncc(Cc3cccc(OCc4cn(CCOCCOCCOCCOCCC(=O)Nc5ccc(C(=O)NCc6ccc(C(=O)NO)cc6)cc5)nn4)c3)s2)n1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	6.85
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q9UBN7	HDAC6	Homo sapiens	Human	PF00850 PF02148	8.0	IC50	ChEMBL
Q8IXJ6	SIRT2	Homo sapiens	Human	PF02146	6.3	IC50	ChEMBL
Q13547	HDAC1	Homo sapiens	Human	PF00850	6.2	IC50	ChEMBL